Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

52.00
BATS BZX Real-Time Price
As of 1:05pm ET
 +0.77 / +1.51%
Today’s Change
49.51
Today|||52-Week Range
72.31
-20.79%
Year-to-Date
TEVA Regular Dividend: TEVA began trading ex-dividend on 05/20/16. A $0.34 dividend will be paid to shareholders of record as of 05/24/16.
Is This the Perfect Time to Buy Teva?
9:39am / TheStreet.com - Paid Partner Content
Down 27%, Is It Time to Buy Allergan Stock? 3 Things You Need to Know
May 13 / MotleyFool.com - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
Allergan (AGN) Stock Up in Pre-Market on Q1 Earnings Beat
May 10 / Zacks.com - Paid Partner Content
AstraZeneca's Severe Asthma Drug Positive in Phase III
May 18 / Zacks.com - Paid Partner Content
Stock Market News for May 10, 2016
May 10 / Zacks.com - Paid Partner Content
5 Stocks We're Never Selling
May 14 / MotleyFool.com - Paid Partner Content
Teva's (TEVA) Stock Gains on Q1 Earnings & Revenue Beat
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.22
Today’s open51.57
Day’s range51.41 - 52.03
Volume112,039
Average volume (3 months)6,250,003
Market cap$52.4B
Dividend yield2.62%
Data as of 1:05pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-48.06%
Earnings growth (this year)-3.25%
Earnings growth (next 5 years)+7.20%
Revenue growth (last year)-3.25%
P/E ratio26.9
Price/Sales2.89
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.39+1.97%
BGNEBeiGene Ltd+0.08+0.29%
DNAIProNAi Therapeutics ...+0.05+0.84%
OASMOasmia Pharmaceutica...+0.09+2.06%
Data as of 2:05pm ET, 05/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers

Search for Jobs